Tenofovir impairs enzyme that stops cells aging This study let us know that NRTI drugs, already known for causing the damage to mitochondrial DNA that leads to peripheral neuropathy, fat loss and some other side-effects, also exert an effect on cellular DNA, and that in this case tenofovir may be the drug to keep an […]
https://www.thebodypro.com/content/70316/innovative-hiv-gene-therapy-study-soon-to-start-en.html
Innovative HIV Gene Therapy Study Soon to Start Enrollment Read More »
https://www.gmanetwork.com/news/story/289657/scitech/science/inactive-hiv-may-provide-hiv-patients-with-immune-protection-study Regards, Nelson Sent from my phone so please excuse misspellings and brevity
Two companies have an effective 100% cure for Hepatitis C without interferon or ribavirin. But this cure is literally being withheld from millions by pharmaceutical giant Gilead Sciences because they are more concerned about profits than human lives. This cure is a combination Bristol-Myers Squibb’s drug daclatasvir and Gilead Science’s GS-7977 (sofosbuvir). When these two drugs were used together, 100
Great summary of the research/development pipeline for new Hep C drugs. It does not include side effects, however. https://www.pipelinereport.org/toc/HCV/dec-treatment-pipeline-update
HCV Treatment Pipeline Update Read More »
Table of medications that can interact with grapefruit
Grapefruit and medication interactions: forbidden fruit or avoidable consequences? Read More »
Calimmune, a small biotechnology company, is giving people a low dose chemo agent (as conditioning) and then infusing them with stem cells that have been modified to inhibit the CCR5 receptor and to contain their own built-in HIV fusion inhibitor peptide, thereby blocking two sites that are essential for HIV infection. The study is
Groundbreaking Gene Therapy Study Gets The Go-Ahead By The FDA Read More »
hello nelson, I have a curiosity about building body after HIV infection.I am guessing that I should have infected in august 1st by sexual intercourse although I used a condom.I am 38 year old and I want to live 30 more years being healthy and strong economically.Being a long term survivor you have some clue.Did
Nelson, how did you manage to survive HIV ? Read More »
By Warren Tong December 5, 2012 Introduction What new HIV medications do we have to look forward to over the next few years? How will these newer drugs improve upon the older ones? To shed some light on these questions, Roy Gulick, M.D., provided an overview at ID Week 2012 of drugs in development. Since the first
Six Promising HIV Drugs in the Pipeline (2013-2014) Read More »
We have repeatedly heard the following statements about multi-drug resistant HIV (MDR-HIV) patients in a host of meetings on treatment access and HIV research: “These patients no longer exist – they’re either dead or have responded to the latest ARVs”; “Only patients who do not adhere to their HIV regimens have MDR-HIV”; and “Our clinic cannot provide expanded access programs (EAPs) due
WORLD AIDS DAY: Time to Help Victims of HIV Drug Studies and Resistance Read More »
From Natap.org HIV, Active HCV, Low Income Tied to Shorter Telomeres, a Cellular Aging Marker3rd International Workshop on HIV and Aging, November 5-6, 2012, Baltimore Mark Mascolini HIV infection, active HCV infection, and income below $15,000 a year independently predicted shorter telomere length in a study of 229 HIV-positive people and 166 HIV-negative people in
HIV, Active HCV, Low Income Tied to Shorter Telomeres, a Cellular Aging Marker Read More »
